WILLIAMS AND JENSEN, PLLC for NOVARTIS INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety and drug counterfeiting; Drug importation; Authorized generics; Drug company settlements including S. 27, Preserve Access to Affordable Generics Act; Prescription drug advertising; Federal preemption for prescription drugs; implementation of the Patient Protection and Affordable Care Act; and drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
Medicare prescription drug benefit; Rebates for Medicare Part D; Independent Payment Advisory Board (IPAB). American Taxpayer Relief Act of 2012.
| Lobbyist | Covered position, as disclosed |
|---|---|
| REBECCA ANDERSON | — |
| JENNY DIJAMES | — |
| SUSAN HIRSCHMANN | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Budget/Appropriations BUD
Funding for pandemic influenza countermeasures
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW B HOEKSTRA | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.